-
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart AssociationCB Newman and and on behalf of the American Heart Association Clinical Lipidology, Lipoprotein, Metabolism and Thrombosis Committee, a Joint Committee of the Council on Atherosclerosis, Thrombosis and Vascular Biology and Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council. -
Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast mediaAzzalini L, Vilca LM, Lombardo F et al.
-
Mode of Death in Heart Failure With Preserved Ejection FractionVaduganathan M, Patel RB, Butler J et al.
-
Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome dataEK Oikonomou, M Marwan, MY Desai et al.
-
Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 TrialsFanaroff AC, Clare R, Pieper KS et al.
-
Generalizing Intensive Blood Pressure Treatment to Adults With Diabetes MellitusSA Berkowitz, JB Sussman, DE Jonas et al.
-
Select Drug-Drug Interactions With Direct Oral AnticoagulantsBS Wiggins, DL Dixon, RR Neyens et al.
-
Variation in Revascularization Practice and Outcomes in Asymptomatic Stable Ischemic Heart DiseaseA Czarnecki, F Qiu, G Elbaz-Greener et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
